Thermo Fisher Scientific · 1 month ago
VP, Project Delivery - Epilepsy & Neuroinflammatory Disorders Team - Remote based in NA
Thermo Fisher Scientific is seeking a Vice President for their Epilepsy team within the Neuroscience Therapeutic Business Unit. This role involves strategic leadership and operational oversight to drive business growth and maintain expertise in the epilepsy field while collaborating globally across various functional groups.
BioinformaticsBiotechnologyCloud Data ServicesConsultingHealth CareLife ScienceManagement Information SystemsOffice SuppliesPrecision Medicine
Responsibilities
Lead and execute the growth strategy for the Epilepsy book of business, driving business expansion through pipeline analysis, market assessment, and enterprise collaboration
Oversee planning, execution, and delivery of therapeutic studies, portfolios, and client engagements
Maintain expertise in the evolving scientific, clinical, and regulatory landscape for epilepsy, including biomarkers, digital endpoints, and precision medicine
Collaborate with Neuroscience leaders to leverage synergies across related therapeutic areas, driving operational efficiency and innovation in study delivery and scientific approaches
Partner with Business Development to retain and expand key client relationships
Implement systems and processes that ensure compliance, quality, and efficiency
Ensure effective management of budgets, forecasts, and profitability targets across programs
Serve as a senior point of contact and executive escalation for key clients, representing the TBU with professionalism, credibility, and scientific integrity
Mentor and develop therapeutic area talent, foster collaboration, accountability, and innovation across global teams
Engage with key opinion leaders, industry consortia, and advocacy networks to strengthen CRG’s leadership and partnerships in epilepsy research
Qualification
Required
Advanced degree (PhD, MD, PharmD, or equivalent) in a relevant scientific discipline required
Deep and current knowledge of the scientific, clinical, regulatory, and competitive landscape related to epilepsy
Strong global awareness and understanding of the development and delivery environment within neurological therapeutics
Proven commercial and financial acumen, with the ability to translate strategies into therapeutic business unit profitability and sustainable growth
Demonstrated executive presence, gravitas, and strategic influence across complex stakeholder networks
Exceptional leadership skills with the ability to motivate, develop, and lead global cross-functional teams through change and growth
Strong customer management skills, including the ability to engage at the executive level, navigate complex negotiations, and drive impactful client outcomes
In-depth understanding of the biopharmaceutical and biotechnology industry, clinical trial operations, and data-driven decision-making
Strong presentation, communication, and interpersonal skills, including excellent command of the English language
Demonstrated learning agility and commitment to continuous professional growth
Ability to travel up to 50%
Preferred
advanced neuroscience background strongly preferred
Company
Thermo Fisher Scientific
Thermo Fisher Scientific is a biotechnology and laboratory equipment company that provides a wide range of scientific products and services.
H1B Sponsorship
Thermo Fisher Scientific has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (272)
2024 (224)
2023 (233)
2022 (342)
2021 (315)
2020 (227)
Funding
Current Stage
Public CompanyTotal Funding
$15.97BKey Investors
National Grid
2025-11-24Post Ipo Debt· $2.42B
2025-09-30Post Ipo Debt· $2.5B
2023-08-07Post Ipo Debt· $2.95B
Leadership Team
Recent News
2026-01-09
EIN Presswire
2026-01-07
Company data provided by crunchbase